ARTIficial Intelligence-based Smartphone Application for Skin Cancer Detection

Launched by UNIVERSITY HOSPITAL, GHENT · Feb 14, 2022

Keywords

ClinConnect Summary

This clinical trial is studying a smartphone application called the Skinvision App®, which aims to help identify skin lesions that might be cancerous and need urgent medical attention. Researchers want to see if this app can effectively preselect suspicious skin spots, making it easier for patients to seek medical advice when needed.

To participate in this trial, you should be between the ages of 65 and 74 and have one or two skin lesions that meet certain criteria, such as a new mole, a mole that looks different from your other moles, or a mole that is changing in size, color, or shape. If you decide to join, you'll need to provide written consent. Participants will use the app to check their skin lesions, and based on the app's findings, they may be advised to see a doctor for further evaluation. This trial is currently recruiting, and everyone's involvement could help improve skin cancer detection in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• * Patients with one or two lesions meeting at least one of the following criteria:
• • New mole in an adult (\> 18 years old);
• • 'Ugly duckling' sign (i.e. mole that looks different from other moles in the same person)
• • Changing mole (size, color, shape or structure);
• • Rapid growing lesion
• • Non-healing lesion
• • Written informed consent of the patient
• Exclusion Criteria:
• • Lack of informed consent for study participation